English
简体中文
Total: £ 56.28
Published Date: 2025-12-13 | Pages: 97 | Tables: 94 | Pharma & Healthcare
The global market for Acyclovir Active Pharmaceutical Ingredient (API) was valued at US$ 1632 million in the year 2024 and is projected to reach a revised size of US$ 2317 million by 2031, growing at a CAGR of 5.0% during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Acyclovir Active Pharmaceutical Ingredient (API) competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
In 2024, global Acyclovir Active Pharmaceutical Ingredient (API) production reached approximately 200,000 tons, with an average global market price of around US$8 per kilogram. In 2024, the global 's total production capacity of Acyclovir Active Pharmaceutical Ingredient (API) reached 250,000 tons units. The industry average gross profit margin of this product reached 42%.Acyclovir active pharmaceutical ingredient (API) is a synthetic purine nucleoside analog, chemically named 9-(2-hydroxyethoxymethyl)guanine. It is a white, odorless crystalline powder and the active ingredient in antiviral drugs. As a systemic antiviral drug, it is primarily used to treat infections caused by herpes simplex virus (HSV) and herpes zoster virus (HZV), including genital herpes, herpes zoster, varicella in immunocompromised individuals, and herpes simplex encephalitis. This API works by inhibiting viral DNA replication. It requires a synthetic process and must meet strict pharmacopoeia standards and quality requirements. Downstream formulations include various dosage forms such as oral immediate-release formulations, granules, injections, and ointments.
The upstream of the acyclovir API supply chain mainly includes the supply of chemical raw materials and intermediates, such as the purine nucleoside analogs and related solvents required for synthesis. The midstream involves the production and manufacturing of the API, including synthetic processes, purification, quality control, and domestic and international registration and certification. The downstream supply chain covers formulation production, which is sold to end users through hospitals, pharmacies, and other channels for the treatment of herpes simplex virus infection, herpes zoster, and other diseases. Furthermore, the industry chain also involves import and export trade, logistics and distribution, and policy regulation. The overall structure is closely interconnected, with upstream raw material supply and downstream formulation market demand jointly driving the stable operation of the industry chain.
The acyclovir active pharmaceutical ingredient (API) market outlook is generally stable, but growth is limited. The global market is projected to maintain moderate growth between 2024 and 2031, with a certain percentage CAGR. The Chinese market is expected to increase its share driven by policy and demand. Driving factors include the continued prevalence of diseases such as herpes simplex virus, a solid global demand base for antiviral drugs, and efficiency improvements brought about by new process technologies. However, the market also faces challenges. For example, acyclovir, as a mature product, is in a highly competitive market with significant price pressure, and downstream formulation manufacturers may reduce their API purchases due to external factors such as the COVID-19 pandemic. In the future, companies need to cope with policy and regulatory changes through technological upgrades and compliant production, and explore emerging markets to maintain competitiveness. The overall market is expected to show a trend of stable volume and stable prices.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Acyclovir Active Pharmaceutical Ingredient (API), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acyclovir Active Pharmaceutical Ingredient (API).
The Acyclovir Active Pharmaceutical Ingredient (API) market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Acyclovir Active Pharmaceutical Ingredient (API) market comprehensively. Regional market sizes, concerning products by Type, by Application, by Application Dosage Forms and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Acyclovir Active Pharmaceutical Ingredient (API) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Application Dosage Forms and by regions.
By Company
Zhejiang Zhebei Pharmaceuticals
Hongyuan Pharmaceuticals
Xinxiang Pharmaceuticals
Hubei Yitai Pharmaceuticals
Zhejiang Chengyi Pharmaceuticals
Shanghai Pharmaceuticals Kangli
Zhejiang Chetou Pharmaceuticals
Mangalam
Vinuthana
Atom pharma
ViSTART
Segment by Type
Purity 98%-99%
Purity ≥ 99%
Others
Segment by Application Dosage Forms
Injection
Tablet
Capsule
Ointment
Others
Segment by Sales Channels
Online Sales
Offline Sales
Segment by Application
Pharmaceuticals
Scientific Research
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Acyclovir Active Pharmaceutical Ingredient (API) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Acyclovir Active Pharmaceutical Ingredient (API) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Acyclovir Active Pharmaceutical Ingredient (API) Market Overview
1.1 Product Definition
1.2 Acyclovir Active Pharmaceutical Ingredient (API) by Type
1.2.1 Global Acyclovir Active Pharmaceutical Ingredient (API) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Purity 98%-99%
1.2.3 Purity ≥ 99%
1.2.4 Others
1.3 Acyclovir Active Pharmaceutical Ingredient (API) by Application Dosage Forms
1.3.1 Global Acyclovir Active Pharmaceutical Ingredient (API) Market Value Comparison by Application Dosage Forms: 2024 VS 2031
1.3.2 Injection
1.3.3 Tablet
1.3.4 Capsule
1.3.5 Ointment
1.3.6 Others
1.4 Acyclovir Active Pharmaceutical Ingredient (API) by Sales Channels
1.4.1 Global Acyclovir Active Pharmaceutical Ingredient (API) Market Value Comparison by Sales Channels: 2024 VS 2031
1.4.2 Online Sales
1.4.3 Offline Sales
1.5 Acyclovir Active Pharmaceutical Ingredient (API) by Application
1.5.1 Global Acyclovir Active Pharmaceutical Ingredient (API) Market Value by Application (2024 VS 2031)
1.5.2 Pharmaceuticals
1.5.3 Scientific Research
1.6 Global Acyclovir Active Pharmaceutical Ingredient (API) Market Size Estimates and Forecasts
1.6.1 Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue 2020-2031
1.6.2 Global Acyclovir Active Pharmaceutical Ingredient (API) Sales 2020-2031
1.6.3 Global Acyclovir Active Pharmaceutical Ingredient (API) Market Average Price (2020-2031)
1.7 Assumptions and Limitations
2 Acyclovir Active Pharmaceutical Ingredient (API) Market Competition by Manufacturers
2.1 Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Acyclovir Active Pharmaceutical Ingredient (API) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Acyclovir Active Pharmaceutical Ingredient (API), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Acyclovir Active Pharmaceutical Ingredient (API), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Acyclovir Active Pharmaceutical Ingredient (API), Product Type & Application
2.7 Global Key Manufacturers of Acyclovir Active Pharmaceutical Ingredient (API), Date of Enter into This Industry
2.8 Global Acyclovir Active Pharmaceutical Ingredient (API) Market Competitive Situation and Trends
2.8.1 Global Acyclovir Active Pharmaceutical Ingredient (API) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Acyclovir Active Pharmaceutical Ingredient (API) Players Market Share by Revenue
2.8.3 Global Acyclovir Active Pharmaceutical Ingredient (API) Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Acyclovir Active Pharmaceutical Ingredient (API) Market Scenario by Region
3.1 Global Acyclovir Active Pharmaceutical Ingredient (API) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Acyclovir Active Pharmaceutical Ingredient (API) Sales by Region: 2020-2031
3.2.1 Global Acyclovir Active Pharmaceutical Ingredient (API) Sales by Region: 2020-2025
3.2.2 Global Acyclovir Active Pharmaceutical Ingredient (API) Sales by Region: 2026-2031
3.3 Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Region: 2020-2031
3.3.1 Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Region: 2020-2025
3.3.2 Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Region: 2026-2031
3.4 North America Acyclovir Active Pharmaceutical Ingredient (API) Market Facts & Figures by Country
3.4.1 North America Acyclovir Active Pharmaceutical Ingredient (API) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Acyclovir Active Pharmaceutical Ingredient (API) Sales by Country (2020-2031)
3.4.3 North America Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Acyclovir Active Pharmaceutical Ingredient (API) Market Facts & Figures by Country
3.5.1 Europe Acyclovir Active Pharmaceutical Ingredient (API) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Acyclovir Active Pharmaceutical Ingredient (API) Sales by Country (2020-2031)
3.5.3 Europe Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Acyclovir Active Pharmaceutical Ingredient (API) Market Facts & Figures by Region
3.6.1 Asia Pacific Acyclovir Active Pharmaceutical Ingredient (API) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Acyclovir Active Pharmaceutical Ingredient (API) Sales by Region (2020-2031)
3.6.3 Asia Pacific Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Acyclovir Active Pharmaceutical Ingredient (API) Market Facts & Figures by Country
3.7.1 Latin America Acyclovir Active Pharmaceutical Ingredient (API) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Acyclovir Active Pharmaceutical Ingredient (API) Sales by Country (2020-2031)
3.7.3 Latin America Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Acyclovir Active Pharmaceutical Ingredient (API) Market Facts & Figures by Country
3.8.1 Middle East and Africa Acyclovir Active Pharmaceutical Ingredient (API) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Acyclovir Active Pharmaceutical Ingredient (API) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Acyclovir Active Pharmaceutical Ingredient (API) Sales by Type (2020-2031)
4.1.1 Global Acyclovir Active Pharmaceutical Ingredient (API) Sales by Type (2020-2025)
4.1.2 Global Acyclovir Active Pharmaceutical Ingredient (API) Sales by Type (2026-2031)
4.1.3 Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Type (2020-2031)
4.2 Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Type (2020-2031)
4.2.1 Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Type (2020-2025)
4.2.2 Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Type (2026-2031)
4.2.3 Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share by Type (2020-2031)
4.3 Global Acyclovir Active Pharmaceutical Ingredient (API) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Acyclovir Active Pharmaceutical Ingredient (API) Sales by Application (2020-2031)
5.1.1 Global Acyclovir Active Pharmaceutical Ingredient (API) Sales by Application (2020-2025)
5.1.2 Global Acyclovir Active Pharmaceutical Ingredient (API) Sales by Application (2026-2031)
5.1.3 Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Application (2020-2031)
5.2 Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Application (2020-2031)
5.2.1 Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Application (2020-2025)
5.2.2 Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Application (2026-2031)
5.2.3 Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share by Application (2020-2031)
5.3 Global Acyclovir Active Pharmaceutical Ingredient (API) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Zhejiang Zhebei Pharmaceuticals
6.1.1 Zhejiang Zhebei Pharmaceuticals Company Information
6.1.2 Zhejiang Zhebei Pharmaceuticals Description and Business Overview
6.1.3 Zhejiang Zhebei Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Zhejiang Zhebei Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolio
6.1.5 Zhejiang Zhebei Pharmaceuticals Recent Developments/Updates
6.2 Hongyuan Pharmaceuticals
6.2.1 Hongyuan Pharmaceuticals Company Information
6.2.2 Hongyuan Pharmaceuticals Description and Business Overview
6.2.3 Hongyuan Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Hongyuan Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolio
6.2.5 Hongyuan Pharmaceuticals Recent Developments/Updates
6.3 Xinxiang Pharmaceuticals
6.3.1 Xinxiang Pharmaceuticals Company Information
6.3.2 Xinxiang Pharmaceuticals Description and Business Overview
6.3.3 Xinxiang Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Xinxiang Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolio
6.3.5 Xinxiang Pharmaceuticals Recent Developments/Updates
6.4 Hubei Yitai Pharmaceuticals
6.4.1 Hubei Yitai Pharmaceuticals Company Information
6.4.2 Hubei Yitai Pharmaceuticals Description and Business Overview
6.4.3 Hubei Yitai Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Hubei Yitai Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolio
6.4.5 Hubei Yitai Pharmaceuticals Recent Developments/Updates
6.5 Zhejiang Chengyi Pharmaceuticals
6.5.1 Zhejiang Chengyi Pharmaceuticals Company Information
6.5.2 Zhejiang Chengyi Pharmaceuticals Description and Business Overview
6.5.3 Zhejiang Chengyi Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Zhejiang Chengyi Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolio
6.5.5 Zhejiang Chengyi Pharmaceuticals Recent Developments/Updates
6.6 Shanghai Pharmaceuticals Kangli
6.6.1 Shanghai Pharmaceuticals Kangli Company Information
6.6.2 Shanghai Pharmaceuticals Kangli Description and Business Overview
6.6.3 Shanghai Pharmaceuticals Kangli Acyclovir Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Shanghai Pharmaceuticals Kangli Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolio
6.6.5 Shanghai Pharmaceuticals Kangli Recent Developments/Updates
6.7 Zhejiang Chetou Pharmaceuticals
6.7.1 Zhejiang Chetou Pharmaceuticals Company Information
6.7.2 Zhejiang Chetou Pharmaceuticals Description and Business Overview
6.7.3 Zhejiang Chetou Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Zhejiang Chetou Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolio
6.7.5 Zhejiang Chetou Pharmaceuticals Recent Developments/Updates
6.8 Mangalam
6.8.1 Mangalam Company Information
6.8.2 Mangalam Description and Business Overview
6.8.3 Mangalam Acyclovir Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Mangalam Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolio
6.8.5 Mangalam Recent Developments/Updates
6.9 Vinuthana
6.9.1 Vinuthana Company Information
6.9.2 Vinuthana Description and Business Overview
6.9.3 Vinuthana Acyclovir Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Vinuthana Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolio
6.9.5 Vinuthana Recent Developments/Updates
6.10 Atom pharma
6.10.1 Atom pharma Company Information
6.10.2 Atom pharma Description and Business Overview
6.10.3 Atom pharma Acyclovir Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Atom pharma Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolio
6.10.5 Atom pharma Recent Developments/Updates
6.11 ViSTART
6.11.1 ViSTART Company Information
6.11.2 ViSTART Description and Business Overview
6.11.3 ViSTART Acyclovir Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2020-2025)
6.11.4 ViSTART Acyclovir Active Pharmaceutical Ingredient (API) Product Portfolio
6.11.5 ViSTART Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Acyclovir Active Pharmaceutical Ingredient (API) Industry Chain Analysis
7.2 Acyclovir Active Pharmaceutical Ingredient (API) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Acyclovir Active Pharmaceutical Ingredient (API) Production Mode & Process Analysis
7.4 Acyclovir Active Pharmaceutical Ingredient (API) Sales and Marketing
7.4.1 Acyclovir Active Pharmaceutical Ingredient (API) Sales Channels
7.4.2 Acyclovir Active Pharmaceutical Ingredient (API) Distributors
7.5 Acyclovir Active Pharmaceutical Ingredient (API) Customer Analysis
8 Acyclovir Active Pharmaceutical Ingredient (API) Market Dynamics
8.1 Acyclovir Active Pharmaceutical Ingredient (API) Industry Trends
8.2 Acyclovir Active Pharmaceutical Ingredient (API) Market Drivers
8.3 Acyclovir Active Pharmaceutical Ingredient (API) Market Challenges
8.4 Acyclovir Active Pharmaceutical Ingredient (API) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Acyclovir Active Pharmaceutical Ingredient (API) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Acyclovir Active Pharmaceutical Ingredient (API) Market Value by Application Dosage Forms, (US$ Million) & (2024 VS 2031)
Table 3. Global Acyclovir Active Pharmaceutical Ingredient (API) Market Value by Sales Channels, (US$ Million) & (2024 VS 2031)
Table 4. Global Acyclovir Active Pharmaceutical Ingredient (API) Market Value by Application (2024 VS 2031) & (US$ Million)
Table 5. Global Acyclovir Active Pharmaceutical Ingredient (API) Market Competitive Situation by Manufacturers in 2024
Table 6. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons) of Key Manufacturers (2020-2025)
Table 7. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue (US$ Million) by Manufacturers (2020-2025)
Table 9. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Share by Manufacturers (2020-2025)
Table 10. Global Market Acyclovir Active Pharmaceutical Ingredient (API) Average Price (US$/Ton) of Key Manufacturers (2020-2025)
Table 11. Global Key Players of Acyclovir Active Pharmaceutical Ingredient (API), Industry Ranking, 2022 VS 2023 VS 2024
Table 12. Global Key Manufacturers of Acyclovir Active Pharmaceutical Ingredient (API), Manufacturing Sites & Headquarters
Table 13. Global Key Manufacturers of Acyclovir Active Pharmaceutical Ingredient (API), Product Type & Application
Table 14. Global Key Manufacturers of Acyclovir Active Pharmaceutical Ingredient (API), Date of Enter into This Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Acyclovir Active Pharmaceutical Ingredient (API) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acyclovir Active Pharmaceutical Ingredient (API) as of 2024)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Acyclovir Active Pharmaceutical Ingredient (API) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 19. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales by Region (2020-2025) & (Tons)
Table 20. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Region (2020-2025)
Table 21. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales by Region (2026-2031) & (Tons)
Table 22. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Region (2026-2031)
Table 23. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Region (2020-2025) & (US$ Million)
Table 24. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share by Region (2020-2025)
Table 25. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Region (2026-2031) & (US$ Million)
Table 26. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share by Region (2026-2031)
Table 27. North America Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. North America Acyclovir Active Pharmaceutical Ingredient (API) Sales by Country (2020-2025) & (Tons)
Table 29. North America Acyclovir Active Pharmaceutical Ingredient (API) Sales by Country (2026-2031) & (Tons)
Table 30. North America Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Country (2020-2025) & (US$ Million)
Table 31. North America Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Country (2026-2031) & (US$ Million)
Table 32. Europe Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 33. Europe Acyclovir Active Pharmaceutical Ingredient (API) Sales by Country (2020-2025) & (Tons)
Table 34. Europe Acyclovir Active Pharmaceutical Ingredient (API) Sales by Country (2026-2031) & (Tons)
Table 35. Europe Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Country (2020-2025) & (US$ Million)
Table 36. Europe Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Country (2026-2031) & (US$ Million)
Table 37. Asia Pacific Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 38. Asia Pacific Acyclovir Active Pharmaceutical Ingredient (API) Sales by Region (2020-2025) & (Tons)
Table 39. Asia Pacific Acyclovir Active Pharmaceutical Ingredient (API) Sales by Region (2026-2031) & (Tons)
Table 40. Asia Pacific Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Region (2020-2025) & (US$ Million)
Table 41. Asia Pacific Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Region (2026-2031) & (US$ Million)
Table 42. Latin America Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Latin America Acyclovir Active Pharmaceutical Ingredient (API) Sales by Country (2020-2025) & (Tons)
Table 44. Latin America Acyclovir Active Pharmaceutical Ingredient (API) Sales by Country (2026-2031) & (Tons)
Table 45. Latin America Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Country (2020-2025) & (US$ Million)
Table 46. Latin America Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Country (2026-2031) & (US$ Million)
Table 47. Middle East and Africa Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 48. Middle East and Africa Acyclovir Active Pharmaceutical Ingredient (API) Sales by Country (2020-2025) & (Tons)
Table 49. Middle East and Africa Acyclovir Active Pharmaceutical Ingredient (API) Sales by Country (2026-2031) & (Tons)
Table 50. Middle East and Africa Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Country (2020-2025) & (US$ Million)
Table 51. Middle East and Africa Acyclovir Active Pharmaceutical Ingredient (API) Revenue by Country (2026-2031) & (US$ Million)
Table 52. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons) by Type (2020-2025)
Table 53. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons) by Type (2026-2031)
Table 54. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Type (2020-2025)
Table 55. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Type (2026-2031)
Table 56. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue (US$ Million) by Type (2020-2025)
Table 57. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue (US$ Million) by Type (2026-2031)
Table 58. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share by Type (2020-2025)
Table 59. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share by Type (2026-2031)
Table 60. Global Acyclovir Active Pharmaceutical Ingredient (API) Price (US$/Ton) by Type (2020-2025)
Table 61. Global Acyclovir Active Pharmaceutical Ingredient (API) Price (US$/Ton) by Type (2026-2031)
Table 62. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons) by Application (2020-2025)
Table 63. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons) by Application (2026-2031)
Table 64. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Application (2020-2025)
Table 65. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Application (2026-2031)
Table 66. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue (US$ Million) by Application (2020-2025)
Table 67. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue (US$ Million) by Application (2026-2031)
Table 68. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share by Application (2020-2025)
Table 69. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share by Application (2026-2031)
Table 70. Global Acyclovir Active Pharmaceutical Ingredient (API) Price (US$/Ton) by Application (2020-2025)
Table 71. Global Acyclovir Active Pharmaceutical Ingredient (API) Price (US$/Ton) by Application (2026-2031)
Table 72. Zhejiang Zhebei Pharmaceuticals Company Information
Table 73. Zhejiang Zhebei Pharmaceuticals Description and Business Overview
Table 74. Zhejiang Zhebei Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 75. Zhejiang Zhebei Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product
Table 76. Zhejiang Zhebei Pharmaceuticals Recent Developments/Updates
Table 77. Hongyuan Pharmaceuticals Company Information
Table 78. Hongyuan Pharmaceuticals Description and Business Overview
Table 79. Hongyuan Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 80. Hongyuan Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product
Table 81. Hongyuan Pharmaceuticals Recent Developments/Updates
Table 82. Xinxiang Pharmaceuticals Company Information
Table 83. Xinxiang Pharmaceuticals Description and Business Overview
Table 84. Xinxiang Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 85. Xinxiang Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product
Table 86. Xinxiang Pharmaceuticals Recent Developments/Updates
Table 87. Hubei Yitai Pharmaceuticals Company Information
Table 88. Hubei Yitai Pharmaceuticals Description and Business Overview
Table 89. Hubei Yitai Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 90. Hubei Yitai Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product
Table 91. Hubei Yitai Pharmaceuticals Recent Developments/Updates
Table 92. Zhejiang Chengyi Pharmaceuticals Company Information
Table 93. Zhejiang Chengyi Pharmaceuticals Description and Business Overview
Table 94. Zhejiang Chengyi Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 95. Zhejiang Chengyi Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product
Table 96. Zhejiang Chengyi Pharmaceuticals Recent Developments/Updates
Table 97. Shanghai Pharmaceuticals Kangli Company Information
Table 98. Shanghai Pharmaceuticals Kangli Description and Business Overview
Table 99. Shanghai Pharmaceuticals Kangli Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 100. Shanghai Pharmaceuticals Kangli Acyclovir Active Pharmaceutical Ingredient (API) Product
Table 101. Shanghai Pharmaceuticals Kangli Recent Developments/Updates
Table 102. Zhejiang Chetou Pharmaceuticals Company Information
Table 103. Zhejiang Chetou Pharmaceuticals Description and Business Overview
Table 104. Zhejiang Chetou Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 105. Zhejiang Chetou Pharmaceuticals Acyclovir Active Pharmaceutical Ingredient (API) Product
Table 106. Zhejiang Chetou Pharmaceuticals Recent Developments/Updates
Table 107. Mangalam Company Information
Table 108. Mangalam Description and Business Overview
Table 109. Mangalam Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 110. Mangalam Acyclovir Active Pharmaceutical Ingredient (API) Product
Table 111. Mangalam Recent Developments/Updates
Table 112. Vinuthana Company Information
Table 113. Vinuthana Description and Business Overview
Table 114. Vinuthana Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 115. Vinuthana Acyclovir Active Pharmaceutical Ingredient (API) Product
Table 116. Vinuthana Recent Developments/Updates
Table 117. Atom pharma Company Information
Table 118. Atom pharma Description and Business Overview
Table 119. Atom pharma Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 120. Atom pharma Acyclovir Active Pharmaceutical Ingredient (API) Product
Table 121. Atom pharma Recent Developments/Updates
Table 122. ViSTART Company Information
Table 123. ViSTART Description and Business Overview
Table 124. ViSTART Acyclovir Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 125. ViSTART Acyclovir Active Pharmaceutical Ingredient (API) Product
Table 126. ViSTART Recent Developments/Updates
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. Acyclovir Active Pharmaceutical Ingredient (API) Distributors List
Table 130. Acyclovir Active Pharmaceutical Ingredient (API) Customers List
Table 131. Acyclovir Active Pharmaceutical Ingredient (API) Market Trends
Table 132. Acyclovir Active Pharmaceutical Ingredient (API) Market Drivers
Table 133. Acyclovir Active Pharmaceutical Ingredient (API) Market Challenges
Table 134. Acyclovir Active Pharmaceutical Ingredient (API) Market Restraints
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
Table 138. Authors List of This Report
List of Figures
Figure 1. Product Picture of Acyclovir Active Pharmaceutical Ingredient (API)
Figure 2. Global Acyclovir Active Pharmaceutical Ingredient (API) Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Acyclovir Active Pharmaceutical Ingredient (API) Market Share by Type: 2024 & 2031
Figure 4. Purity 98%-99% Product Picture
Figure 5. Purity ≥ 99% Product Picture
Figure 6. Others Product Picture
Figure 7. Global Acyclovir Active Pharmaceutical Ingredient (API) Market Value by Application Dosage Forms, (US$ Million) & (2020-2031)
Figure 8. Global Acyclovir Active Pharmaceutical Ingredient (API) Market Share by Application Dosage Forms: 2024 VS 2031
Figure 9. Injection Product Picture
Figure 10. Tablet Product Picture
Figure 11. Capsule Product Picture
Figure 12. Ointment Product Picture
Figure 13. Others Product Picture
Figure 14. Global Acyclovir Active Pharmaceutical Ingredient (API) Market Value by Sales Channels, (US$ Million) & (2020-2031)
Figure 15. Global Acyclovir Active Pharmaceutical Ingredient (API) Market Share by Sales Channels: 2024 VS 2031
Figure 16. Online Sales Product Picture
Figure 17. Offline Sales Product Picture
Figure 18. Global Acyclovir Active Pharmaceutical Ingredient (API) Market Value by Application (2020-2031) & (US$ Million)
Figure 19. Global Acyclovir Active Pharmaceutical Ingredient (API) Market Share by Application: 2024 & 2031
Figure 20. Pharmaceuticals
Figure 21. Scientific Research
Figure 22. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 23. Global Acyclovir Active Pharmaceutical Ingredient (API) Market Size (2020-2031) & (US$ Million)
Figure 24. Global Acyclovir Active Pharmaceutical Ingredient (API) Sales (2020-2031) & (Tons)
Figure 25. Global Acyclovir Active Pharmaceutical Ingredient (API) Average Price (US$/Ton) & (2020-2031)
Figure 26. Acyclovir Active Pharmaceutical Ingredient (API) Report Years Considered
Figure 27. Acyclovir Active Pharmaceutical Ingredient (API) Sales Share by Manufacturers in 2024
Figure 28. Global Acyclovir Active Pharmaceutical Ingredient (API) Revenue Share by Manufacturers in 2024
Figure 29. Global 5 and 10 Largest Acyclovir Active Pharmaceutical Ingredient (API) Players: Market Share by Revenue in Acyclovir Active Pharmaceutical Ingredient (API) in 2024
Figure 30. Acyclovir Active Pharmaceutical Ingredient (API) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 31. Global Acyclovir Active Pharmaceutical Ingredient (API) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 32. North America Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Country (2020-2031)
Figure 33. North America Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share by Country (2020-2031)
Figure 34. United States Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Canada Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Europe Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Country (2020-2031)
Figure 37. Europe Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share by Country (2020-2031)
Figure 38. Germany Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. France Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. U.K. Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Italy Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Russia Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Asia Pacific Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Region (2020-2031)
Figure 44. Asia Pacific Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share by Region (2020-2031)
Figure 45. China Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Japan Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. South Korea Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. India Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Australia Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. China Taiwan Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Southeast Asia Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Latin America Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Country (2020-2031)
Figure 53. Latin America Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share by Country (2020-2031)
Figure 54. Mexico Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Brazil Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Argentina Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Colombia Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Middle East and Africa Acyclovir Active Pharmaceutical Ingredient (API) Sales Market Share by Country (2020-2031)
Figure 59. Middle East and Africa Acyclovir Active Pharmaceutical Ingredient (API) Revenue Market Share by Country (2020-2031)
Figure 60. Turkey Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 61. Saudi Arabia Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 62. UAE Acyclovir Active Pharmaceutical Ingredient (API) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 63. Global Sales Market Share of Acyclovir Active Pharmaceutical Ingredient (API) by Type (2020-2031)
Figure 64. Global Revenue Market Share of Acyclovir Active Pharmaceutical Ingredient (API) by Type (2020-2031)
Figure 65. Global Acyclovir Active Pharmaceutical Ingredient (API) Price (US$/Ton) by Type (2020-2031)
Figure 66. Global Sales Market Share of Acyclovir Active Pharmaceutical Ingredient (API) by Application (2020-2031)
Figure 67. Global Revenue Market Share of Acyclovir Active Pharmaceutical Ingredient (API) by Application (2020-2031)
Figure 68. Global Acyclovir Active Pharmaceutical Ingredient (API) Price (US$/Ton) by Application (2020-2031)
Figure 69. Acyclovir Active Pharmaceutical Ingredient (API) Value Chain
Figure 70. Channels of Distribution (Direct Vs Distribution)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
